Squarepoint’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Sell
13,774
-20,511
-60% -$150K ﹤0.01% 4058
2025
Q4
$210K Buy
+34,285
New +$370K ﹤0.01% 3838
2025
Q3
Sell
-35,088
Closed -$456K 4340
2025
Q2
$456K Buy
+35,088
New +$415K ﹤0.01% 3350
2025
Q1
Sell
-10,102
Closed -$171K 4537
2024
Q4
$171K Sell
10,102
-22,752
-69% -$428K ﹤0.01% 4528
2024
Q3
$763K Buy
32,854
+3,355
+11% +$71.8K ﹤0.01% 2811
2024
Q2
$718K Buy
+29,499
New +$895K ﹤0.01% 2801
2024
Q1
Sell
-8,795
Closed -$312K 3987
2023
Q4
$277K Sell
8,795
-5,252
-37% -$125K ﹤0.01% 3410
2023
Q3
$359K Buy
+14,047
New +$433K ﹤0.01% 3034
2021
Q2
Sell
-8,609
Closed -$356K 3201
2021
Q1
$356K Buy
+8,609
New +$513K ﹤0.01% 2277
2020
Q3
Sell
-4,796
Closed -$224K 2474
2020
Q2
$224K Buy
+4,796
New +$165K ﹤0.01% 1768
2020
Q1
Sell
-54,600
Closed -$594K 1844
2019
Q4
$594K Buy
54,600
+16,600
+44% +$174K ﹤0.01% 1662
2019
Q3
$390K Buy
+38,000
New +$411K ﹤0.01% 1746
2017
Q1
Sell
-5,657
Closed -$83K 1512
2016
Q4
$83K Buy
+5,657
New +$84.6K ﹤0.01% 1648

Other funds holding ARCT